Kenvue (KVUE) Financial Analysis & Valuation | Quarter Chart
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tyleno... more
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segm... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $33.93B | Exchange | NYSE |
| Sector | Consumer Defensive | Industry | Household & Personal Products |
| Country | US | CEO | Kirk L. Perry |
| IPO Date | 2023-05-04 | CAGR | 0.91% |
| Employees | 21,890 | Website | www.kenvue.com |
| Div. Yield | 9.1% | Payout Ratio | 1% |
| Buy Back Yield | 0.37% | Total Yield | 9.47% |
KVUE chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $41.14B | P/E | 14.97 | Forward P/E | 14.25 | PEG | 2.45 |
| P/S | 1.13 | P/B | 1.65 | P/CF | 7.49 | P/FCF | 8.23 |
| Sales | $15.41B | Sales 1Y | 1.76% | Sales 3Y | -0.01% | Sales 5Y | — |
| EPS | $1.18 | EPS 1Y | 17.57% | EPS 3Y | -16.37% | EPS 5Y | — |
| Sales QoQ | 1.18% | EPS QoQ | -4% | Sales QoQ Avg | 0.77% | EPS QoQ Avg | 4.87% |
| Gross Margin | 58.19% | Operating Margin | 19.52% | Profit Margin | 10.76% | ROCE | 14.41% |
| ROA | 6% | ROE | 16% | Altman Z Score | 2.15 | Piotroski Score | 5 |
| Current Ratio | 1.01 | Quick Ratio | 0.71 | Cash Ratio | 0.19 | Op. CF Ratio | 0.12 |
| Debt/Equity | 0.8 | Debt/Assets | 0.32 | Lt Debt/Equity | 0.67 | Lt Debt/Cap. | 0.4 |
| Intrst Cov. | 8 | Inventory Turnover | 3.74 | Asset Turnover | 0.58 | Receivables Turnover | — |
| Enterprise Value | $41.14B | P/E Ratio | 14.97 |
| Forward P/E | 14.25 | PEG Ratio | 2.45 |
| P/S Ratio | 1.13 | P/B Ratio | 1.65 |
| P/CF Ratio | 7.49 | P/FCF Ratio | 8.23 |
| EPS | $1.18 | EPS Growth 1Y | 17.57% |
| EPS Growth 3Y | -16.37% | EPS Growth 5Y | — |
| Revenue Growth 1Y | 1.76% | Gross Margin | 58.19% |
| Operating Margin | 19.52% | Profit Margin | 10.76% |
| ROE | 16% | ROA | 6% |
| ROCE | 14.41% | Current Ratio | 1.01 |
| Quick Ratio | 0.71 | Cash Ratio | 0.19 |
| Debt/Equity | 0.8 | Interest Coverage | 8 |
| Altman Z Score | 2.15 | Piotroski Score | 5 |
Kenvue (KVUE) valuation & financials
Kenvue (KVUE) has a market capitalization of $33.93B and trades at a price-to-earnings ratio of 15.0. It operates in the Consumer Defensive sector (Household & Personal Products).
Kenvue's revenue grew +1.8% over the last year.
Kenvue's next earnings report is scheduled for November 2, 2026 before market open (provider scheduled date); analysts estimate EPS of $0.28. Check the earnings calendar to see all companies reporting this week.
Compare with other Consumer Defensive companies: Walmart (WMT) · Costco (COST) · Coca-Cola (KO) · Procter & Gamble (PG) · Philip Morris (PM) · Nestlé (NESN.SW)